No Data
Kangyuan Pharmaceutical (301281.SZ): Currently not involved in medical consultation business.
Gelonghui November 5th, Ke Yuan Pharmaceuticals (301281.SZ) stated on the investor interaction platform that the company is mainly engaged in the research and development, production, and sales of chemical raw materials and their formulation products, and currently does not involve medical consulting businesses.
Express News | Kexin Pharmaceutical: Fully-owned subsidiary account at banks frozen.
Keyuan Pharmaceutical: Report for the third quarter of 2024
Express News | Three consecutive boardings of Keyuan Pharmaceutical: net income in the first three quarters decreased by 40.38% year-on-year.
Express News | Kelun Pharmaceutical: The net income in the first three quarters decreased by 40.38% year-on-year.
A-share chemical pharmaceutical sector surges, Keyuan Pharmaceuticals hits the daily limit of 20%.
Glory 24th October｜Koyuan pharmaceutical rose by 20cm, Wuxi Jinghai rose by more than 10%, Chuanning Biology, hunan er-kang pharmaceutical, Shanxi Zhendong Pharmaceutical, Shandong Sito Bio-technology, Nanjing Hicin Pharmaceutical and others followed the rise.
No Data
No Data